Vest Financial LLC Sells 24,766 Shares of Cardinal Health, Inc. $CAH

Vest Financial LLC decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 5.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 414,609 shares of the company’s stock after selling 24,766 shares during the quarter. Cardinal Health comprises 1.0% of Vest Financial LLC’s investment portfolio, making the stock its 14th largest holding. Vest Financial LLC owned 0.17% of Cardinal Health worth $69,654,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CAH. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health in the 1st quarter valued at approximately $26,000. Jones Financial Companies Lllp boosted its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. GW&K Investment Management LLC boosted its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares during the period. Garde Capital Inc. bought a new stake in Cardinal Health during the first quarter worth approximately $52,000. Finally, Zions Bancorporation National Association UT bought a new stake in Cardinal Health during the first quarter worth approximately $52,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.2%

CAH opened at $156.86 on Monday. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The stock has a market capitalization of $37.27 billion, a price-to-earnings ratio of 24.32, a P/E/G ratio of 1.33 and a beta of 0.71. The business has a 50 day moving average of $152.09 and a 200-day moving average of $151.31.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the prior year, the business earned $1.84 earnings per share. Cardinal Health’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CAH shares. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $166.00.

Insiders Place Their Bets

In related news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 in the last ninety days. 0.12% of the stock is currently owned by insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.